Welcome to our dedicated page for Ecolab news (Ticker: ECL), a resource for investors and traders seeking the latest updates and insights on Ecolab stock.
Ecolab Inc. reports developments in water, hygiene and infection prevention solutions and services for customers across food, healthcare, data centers, microelectronics, life sciences, hospitality and other industrial markets. Company news commonly covers operating results, dividends, annual-meeting matters, pricing and cost actions, and updates to its global service model.
Product and business updates include AI-enabled water intelligence tools such as Ecolab Water Navigator IQ, Life Sciences bioprocessing capabilities, purification technologies and applications labs, and water-management and sanitation offerings used in customer operations. News also tracks capital-return actions, supply-chain cost responses and governance disclosures tied to its common stock.
Ecolab, in partnership with Repligen , announced the commercial launch of DurA Cycle Affinity Resin, designed for large-scale purification in biologic manufacturing. This product, launched at BIO 2024 in San Diego, targets efficient monoclonal antibody production, reducing costs for biologic drug developers. The launch reflects Ecolab's ongoing commitment to bioprocessing innovations, following two other resins launched in the past eighteen months. The partnership aims to address complex challenges in biologic manufacturing and is bolstered by Ecolab's investment in a new production facility in Landenberg, PA, complementing its UK-based facility.
Ecolab will webcast a presentation by its Chairman and CEO, Christophe Beck, at the William Blair Growth Stock Conference on June 4, 2024. The event will start at 11:40 a.m. Eastern Time and will last for about 30 minutes. This webcast will be accessible via Ecolab's investor website, with a replay available until June 28, 2024.
Ecolab has released its 2023 Growth & Impact Report, highlighting its economic, environmental, social, and governance achievements. The report details significant progress toward Ecolab's 2030 Positive Impact goals. Key milestones in 2023 include conserving 226 billion gallons of water, providing safe food to 1.4 billion people, and avoiding 3.8 million metric tons of greenhouse gas emissions. Ecolab also reached 100% renewable electricity in its European operations and advanced its electric vehicle conversion efforts in North America. Additional achievements include AWS certifications in Monterrey and Nanjing, donating $18.5 million to global communities, and launching the California Water Resilience Initiative. These accomplishments underscore Ecolab's mission to integrate science-based solutions, enhance business health, and drive sustainability.
Ecolab and HeiQ Chrisal collaborate to launch Maxx Synbiotic cleaning products at Interclean in Amsterdam, introducing advanced synbiotic cleaning technology to the European market. The products deliver immediate, microscopic-level cleaning, efficient odor reduction, and support for a well-balanced microbiome on surfaces. HeiQ's technology has been validated in scientific studies, offering a promising future for the cleaning industry.
Ecolab Inc. announced the election of twelve director nominees for a one-year term, approval of executive officers' compensation, and ratification of an accounting firm at its annual meeting. A stockholder proposal on an independent board chair policy was not approved. The final vote tabulation will be reported to the SEC.
Ecolab Inc. announced a regular quarterly cash dividend of $0.57 per common share, to be paid on July 15, 2024, to shareholders of record on June 18, 2024. This marks the 87th consecutive year of cash dividends being paid on Ecolab's common stock.
Ecolab Inc. reported very strong first-quarter performance with diluted EPS at $1.43 and adjusted diluted EPS at $1.34, a 52% increase. Sales grew by 5%, organic sales by 5%, and operating income margin by 13.8% to 14.7%. Ecolab has agreed to sell its global surgical solutions business for $950 million. The outlook for 2024 includes an adjusted diluted EPS range of $6.40 - $6.70, a 23% - 29% increase.
Summary not available.
Summary not available.
Summary not available.